Drug Database
Back to search

United States· US:37808-585_4589467b-a9e7-ec2b-e063-6394a90ade30

Stool Softener

A docusate sodium product containing docusate sodium, registered in United States by HEB. The same ATC class is registered in 5 of our 19 countries.

ATC A06AA02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedStool SoftenerATCA06AA02REGISTER NO.US:37808-585_4589467b…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about docusate sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Docusate sodium is registered in 5 of 19 countries.

Countries holding a registration under ATC A06AA02 (docusate sodium), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose
Search docusate sodium products by name

Docusate sodium · ATC A06AA02

5 / 19 countries

  • Canada
  • Japan
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DOCUSATE SODIUM
Manufacturer
HEB
Country
United States (US)
ATC code
A06AA02
ATC class
Docusate sodium
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    3780858514
    140 CAPSULE, LIQUID FILLED in 1 BOTTLE (37808-585-14)
  • ndc11
    37808-585-14

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for docusate sodium.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check docusate sodium against other medicinesHow interaction checks work

Docusate sodium · interactions on record

4 records

  • 3 moderate
  • 1 minor

Most severe, free to view

  • Liquid paraffinA06AA01moderate
  • PhenolphthaleinA06AB04moderate
  • LactuloseA06AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Docusate sodium in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All docusate sodium products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Belgium · Norgalax
  • France · Jamylene, Norgalax
  • United Kingdom (Northern Ireland) · Dioctyl, Docusate Sodium Adult Typharm
  • Ireland · Waxsol
  • Luxembourg · Norgalax
  • Netherlands · Norgalax
  • Poland · Laxol, Ulgix Laxi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d076ed86-cf21-48e1-9450-ebff4a2b596b
GET /v1/drugs/d076ed86-cf21-48e1-9450-ebff4a2b596b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "DOCUSATE SODIUM",
  "productndc": "37808-585",
  "dosage_form": "CAPSULE, LIQUID FILLED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "M007",
  "marketing_category": "OTC MONOGRAPH DRUG"
}
API referenceMCP serverPlans

See everything about docusate sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console